quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:41:17·267d
SECFiling
Office Properties Income Trust logo

SEC Form 10-Q filed by Office Properties Income Trust

OPI· Office Properties Income Trust
Finance
Original source

Companies

  • OPI
    Office Properties Income Trust
    Finance

Recent analyst ratings

  • Mar 7UpdateRBC Capital Mkts$14.00
  • Dec 14UpdateMorgan Stanley$21.00
  • Sep 30UpdateMorgan Stanley$22.00

Related

  • SEC161d
    SEC Form 25-NSE filed by Office Properties Income Trust
  • SEC168d
    Office Properties Income Trust filed SEC Form 8-K: Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Financial Statements and Exhibits
  • SEC175d
    Office Properties Income Trust filed SEC Form 8-K: Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Events That Accelerate or Increase a Direct Financial Obligation, Regulation FD Disclosure, Financial Statements and Exhibits
  • SEC175d
    Office Properties Income Trust filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
  • PR175d
    Office Properties Income Trust Enters into Restructuring Support Agreement with Noteholders to Reduce Debt and Strengthen Balance Sheet
  • SEC189d
    Office Properties Income Trust filed SEC Form 8-K: Other Events
  • INSIDER217d
    Director Portnoy Adam D. covered exercise/tax liability with 2,108 units of Common Shares of Beneficial Interest, decreasing direct ownership by 0.98% to 212,329 units (SEC Form 4)
  • INSIDER217d
    Director Clark Jennifer B covered exercise/tax liability with 7,858 units of Common Shares of Beneficial Interest, decreasing direct ownership by 5% to 135,916 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022